Akoya Biosciences, Inc. Annual Income Tax Expense (Benefit) in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Akoya Biosciences, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2020 to 2023.
  • Akoya Biosciences, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $47K, a 161% increase year-over-year.
  • Akoya Biosciences, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $103K, a 145% increase year-over-year.
  • Akoya Biosciences, Inc. annual Income Tax Expense (Benefit) for 2023 was $40K, a 67.5% decline from 2022.
  • Akoya Biosciences, Inc. annual Income Tax Expense (Benefit) for 2022 was $123K.
  • Akoya Biosciences, Inc. annual Income Tax Expense (Benefit) for 2021 was -$140K, a 433% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $40K -$83K -67.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-05
2022 $123K +$263K Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 -$140K -$182K -433% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-07
2020 $42K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.